Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial.
Journal: JAMA neurology
Published: August 10, 2026
Prenatal Diagnosis of Spinal Muscular Atrophy Facilitates Ultrarapid Treatment After Birth.
Journal: Pediatric neurology
Published: November 05, 2025
Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross-Trial Comparison.
Journal: Muscle & nerve
Published: October 09, 2025
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial.
Journal: Neurology and therapy
Published: September 10, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Journal: The New England journal of medicine
Published: April 09, 2025
Concurrent Inclusion Body Myositis and Late Onset Pompe Disease: A Case Report.
Journal: Muscle & nerve
Published: February 03, 2025
Development and Validation of a Novel, Disease-Specific, Caregiver-Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported-Health Index (DMDCR-HI).
Journal: Muscle & nerve
Published: January 10, 2025
Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.
Journal: Neurology. Genetics
Published: November 26, 2024
Access to novel therapies for Duchenne muscular dystrophy-Insights from expert treating physicians.
Journal: Annals of the Child Neurology Society
Published: May 08, 2024
Last Updated: 09/26/2026